A detailed history of James Hambro & Partners transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, James Hambro & Partners holds 222,204 shares of TMO stock, worth $123 Million. This represents 4.8% of its overall portfolio holdings.

Number of Shares
222,204
Previous 209,453 6.09%
Holding current value
$123 Million
Previous $130 Million 10.77%
% of portfolio
4.8%
Previous 5.75%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$501.29 - $612.85 $6.39 Million - $7.81 Million
12,751 Added 6.09%
222,204 $116 Million
Q3 2024

Oct 21, 2024

BUY
$531.86 - $624.21 $6 Million - $7.04 Million
11,276 Added 5.69%
209,453 $130 Million
Q2 2024

Jul 16, 2024

BUY
$541.52 - $599.02 $2.82 Million - $3.12 Million
5,213 Added 2.7%
198,177 $110 Million
Q1 2024

Apr 26, 2024

BUY
$528.82 - $599.43 $2.68 Million - $3.04 Million
5,071 Added 2.7%
192,964 $112 Million
Q4 2023

Jan 19, 2024

BUY
$431.41 - $532.94 $7.16 Million - $8.84 Million
16,594 Added 9.69%
187,893 $99.7 Million
Q3 2023

Oct 24, 2023

BUY
$498.29 - $574.41 $6.94 Million - $8.01 Million
13,937 Added 8.86%
171,299 $86.7 Million
Q2 2023

Jul 20, 2023

BUY
$508.46 - $591.13 $4.17 Million - $4.84 Million
8,193 Added 5.49%
157,362 $82.1 Million
Q1 2023

Apr 21, 2023

BUY
$535.0 - $604.82 $1.55 Million - $1.75 Million
2,896 Added 1.98%
149,169 $86 Million
Q4 2022

Jan 25, 2023

BUY
$484.71 - $571.37 $270,952 - $319,395
559 Added 0.38%
146,273 $80.6 Million
Q3 2022

Oct 20, 2022

SELL
$507.19 - $604.49 $2.16 Million - $2.58 Million
-4,263 Reduced 2.84%
145,714 $74 Million
Q2 2022

Jul 22, 2022

SELL
$500.9 - $612.21 $34,562 - $42,242
-69 Reduced 0.05%
149,977 $81.5 Million
Q1 2022

May 05, 2022

BUY
$524.0 - $644.92 $94,844 - $116,730
181 Added 0.12%
150,046 $88.7 Million
Q4 2021

Feb 01, 2022

BUY
$569.0 - $667.24 $264,016 - $309,599
464 Added 0.31%
149,865 $100 Million
Q3 2021

Nov 05, 2021

BUY
$509.53 - $609.78 $4.01 Million - $4.8 Million
7,866 Added 5.56%
149,401 $85.3 Million
Q2 2021

Jul 20, 2021

BUY
$441.0 - $508.24 $4.54 Million - $5.23 Million
10,286 Added 7.84%
141,535 $71.4 Million
Q1 2021

Apr 28, 2021

BUY
$439.85 - $518.83 $5.24 Million - $6.18 Million
11,906 Added 9.98%
131,249 $59.9 Million
Q4 2020

Jan 14, 2021

BUY
$435.06 - $527.66 $4.07 Million - $4.93 Million
9,352 Added 8.5%
119,343 $55.6 Million
Q3 2020

Oct 13, 2020

BUY
$359.77 - $441.52 $31.9 Million - $39.2 Million
88,792 Added 418.85%
109,991 $48.5 Million
Q2 2020

Jul 13, 2020

BUY
$275.2 - $362.34 $5.28 Million - $6.96 Million
19,199 Added 959.95%
21,199 $7.67 Million
Q4 2018

Jan 17, 2019

SELL
$208.47 - $251.98 $417,565 - $504,715
-2,003 Reduced 50.04%
2,000 $447,000
Q2 2018

Jul 12, 2018

BUY
$203.14 - $219.53 $609 - $658
3 Added 0.08%
4,003 $829,000
Q4 2017

Feb 13, 2018

BUY
$182.03 - $200.37 $728,120 - $801,480
4,000
4,000 $760,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $217B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track James Hambro & Partners Portfolio

Follow James Hambro & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Hambro & Partners, based on Form 13F filings with the SEC.

News

Stay updated on James Hambro & Partners with notifications on news.